Natixis’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
Natixis's CDNA Position: Q3 2026 in Review
Natixis opened a new position in CareDx (CDNA) in Q3 2026: 540 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #1037 among its holdings. This is a return to the name: Natixis previously reported a position in CDNA as recently as Q4 2021.
Natixis first reported a position in CDNA in Q2 2021 and has held it in 4 quarters since. The position peaked at $13.7M in Q3 2021. 140 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.
- Natixis held 540 shares of CareDx worth $35.1K as of Q3 2026.
- CareDx was a new Natixis position in Q3 2026.
- CareDx made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #1037 holding.
- Natixis first reported a position in CareDx in Q2 2021 and has held it in 4 quarters since.
- Natixis's CareDx position peaked at $13.7M in Q3 2021.
- 140 funds tracked by Wall St. Rank held CareDx as of Q3 2026.
Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.